NasdaqGS:TRINCapital Markets
Does Trinity Capital’s US$50 Million Neuromodulation Bet Recast Its Medtech Strategy For TRIN Investors?
Trinity Capital Inc. recently committed US$50,000,000 in growth capital to Cala Health, a bioelectronic medicine company whose FDA-cleared Cala kIQ System offers individualized neuromodulation therapy for hand tremors in essential tremor and Parkinson’s disease patients.
This funding highlights Trinity Capital’s increasing exposure to innovative medical technology, tying its lending portfolio more closely to emerging wearable treatment platforms.
Next, we’ll explore how this US$50,000,000...